Furthermore, knockdown of ISG15 enhances the ubiquitination of USP18, leading to a reduction in the accumulation of USP18 in sorafenib-treated HCC cells (Fig. 5H and Supplementary Fig. S5E). The gene discussed is USP18; the disease is hepatocellular carcinoma.